These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33503805)

  • 1. Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3.
    Lombardi APG; Cavalheiro RP; Porto CS; Vicente CM
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
    Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS
    Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen Receptors Promote Migration, Invasion and Colony Formation of the Androgen-Independent Prostate Cancer Cells PC-3 Through β-Catenin Pathway.
    Lombardi APG; Vicente CM; Porto CS
    Front Endocrinol (Lausanne); 2020; 11():184. PubMed ID: 32328032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of estrogen receptor beta (ERβ) regulates the expression of N-cadherin, E-cadherin and β-catenin in androgen-independent prostate cancer cells.
    Silva RS; Lombardi APG; de Souza DS; Vicente CM; Porto CS
    Int J Biochem Cell Biol; 2018 Mar; 96():40-50. PubMed ID: 29341930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptors localization and signaling pathways in DU-145 human prostate cancer cells.
    Souza DS; Lombardi APG; Vicente CM; Lucas TFG; Erustes AG; Pereira GJS; Porto CS
    Mol Cell Endocrinol; 2019 Mar; 483():11-23. PubMed ID: 30660702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells.
    Pisolato R; Lombardi AP; Vicente CM; Lucas TF; Lazari MF; Porto CS
    Steroids; 2016 Mar; 107():74-86. PubMed ID: 26742628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3.
    Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of ERbeta increases levels of phosphorylated nNOS and NO production through a Src/PI3K/Akt-dependent pathway in hypothalamic neurons.
    Gingerich S; Krukoff TL
    Neuropharmacology; 2008 Oct; 55(5):878-85. PubMed ID: 18652836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway.
    Hou X; Zhao M; Wang T; Zhang G
    Oncol Rep; 2014 Mar; 31(3):1175-82. PubMed ID: 24366110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
    Benitez DA; Pozo-Guisado E; Clementi M; Castellón E; Fernandez-Salguero PM
    Br J Cancer; 2007 May; 96(10):1595-604. PubMed ID: 17486135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways.
    Górowska-Wójtowicz E; Hejmej A; Kamińska A; Pardyak L; Kotula-Balak M; Dulińska-Litewka J; Laidler P; Bilińska B
    Toxicol In Vitro; 2017 Apr; 40():324-335. PubMed ID: 28163245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease.
    Zellweger T; Stürm S; Rey S; Zlobec I; Gsponer JR; Rentsch CA; Terracciano LM; Bachmann A; Bubendorf L; Ruiz C
    Endocr Relat Cancer; 2013 Jun; 20(3):403-13. PubMed ID: 23580588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
    Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
    Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen.
    Haynes MP; Li L; Sinha D; Russell KS; Hisamoto K; Baron R; Collinge M; Sessa WC; Bender JR
    J Biol Chem; 2003 Jan; 278(4):2118-23. PubMed ID: 12431978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors regulate galectin‑3 in androgen‑independent DU‑145 prostate cancer cells.
    Souza DS; Macheroni C; Vicente CM; Cavalheiro RP; Campo VL; Porto CS
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.
    Ciarlo M; Benelli R; Barbieri O; Minghelli S; Barboro P; Balbi C; Ferrari N
    Int J Cancer; 2012 Aug; 131(3):582-90. PubMed ID: 22015967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.